---
figid: PMC9671114__fcimb-12-965471-g006
pmcid: PMC9671114
image_filename: fcimb-12-965471-g006.jpg
figure_link: /pmc/articles/PMC9671114/figure/f6/
number: FigureÂ 6
figure_title: ''
caption: 'level 3 Metabolic pathway analysis based on a pairwise comparison among
  the three groups. (A) Comparison between the pre-treatment subgroup and the control
  group. (B) Comparison between the pre-treatment subgroup and the post-treatment
  subgroup. (C) Comparison between the post-treatment subgroup and the control subgroup.
  (D, E) Differences in alanine, aspartate, glutamate metabolism, and differences
  in citrate cycle (TCA cycle), respectively. *FDR<0.05, **FDR<0.01, ***FDR<0.001.
  Red: upregulation. D: pre-treatment group, S: post-treatment group, J: control group.'
article_title: Changes and significance of gut microbiota in children with focal epilepsy
  before and after treatment.
citation: Changci Zhou, et al. Front Cell Infect Microbiol. 2022;12:965471.
year: '2022'

doi: 10.3389/fcimb.2022.965471
journal_title: Frontiers in Cellular and Infection Microbiology
journal_nlm_ta: Front Cell Infect Microbiol
publisher_name: Frontiers Media S.A.

keywords:
- gut microbiota
- epilepsy
- focal onset
- children
- 16S rDNA gene sequencing

---
